`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`_______________
`
`Case IPR2021-00880
`Patent No. 9,669,069 B2
`_______________
`
`DECLARATION OF JEREMY COBB
`
`1
`
`Exhibit 2047
`Page 01 of 04
`
`
`
`I, Jeremy Cobb, do hereby declare as follows:
`
`1.
`
`I am a member in good standing of the Maryland State Bar (2012)
`
`and the District of Columbia Bar (2013), as well as the following federal court:
`
`U.S. Court of Appeals for the Federal Circuit (2012).
`
`2.
`
`I am a senior associate at the law firm of Arnold & Porter Kaye
`
`Scholer LLP (“Arnold & Porter”). I began working at Arnold & Porter in October
`
`2021, and prior to that was an associate at Covington & Burling LLP for nine
`
`years.
`
`3.
`
`I am an experienced litigating attorney with over nine years in private
`
`law practice, and substantial experience with patent litigation. I have been counsel
`
`in at least fifteen patent infringement matters, including in various district courts
`
`across the country, the Patent Trial & Appeal Board, and the Federal Circuit. My
`
`patent litigation experience includes cases related to biologics and small molecules.
`
`4.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`6.
`
`I have had no sanctions or contempt citations imposed against me
`
`by any court or administrative body.
`
`2
`
`Exhibit 2047
`Page 02 of 04
`
`
`
`7.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in 37 C.F.R. § 42.
`
`8.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`9.
`
`I have applied to appear pro hac vice in one other proceeding before
`
`the USPTO: IPR2016-00458. The USPTO granted my pro hac vice application in
`
`IPR2016-00458.
`
`10. Deborah E. Fishman (Reg. No. 48,621) and Alice S. Ho (Lim. Rec.
`
`No. L1162) are experienced registered patent attorneys with whom I have worked
`
`closely and will continue to do so.
`
`11.
`
`I have significant familiarity with the subject matter at issue in this
`
`proceeding and have substantive knowledge of the patent at issue (U.S. Patent No.
`
`9,669,069 (the “’069 Patent”), including its prosecution history, related patents,
`
`and the scientific field to which the ’069 Patent is addressed. A significant amount
`
`of my time since October 2021 has been spent working on issues related to the ’069
`
`Patent and Patent Owner’s commercial product, Eylea®. In doing so, I have
`
`thoroughly reviewed the pleadings and the prior art in support of the patentability of
`
`the ’069 Patent. I have also worked with Patent Owner’s expert Dr. Diana Do.
`
`3
`
`Exhibit 2047
`Page 03 of 04
`
`
`
`Therefore, I have a substantial familiarity with the subject matter of this
`
`proceeding.
`
`12.
`
`In addition, I have a Bachelor’s of Science degree in chemistry from
`
`Butler University, a Master’s degree in organic chemistry from the University of
`
`Illinois-Urbana Champaign, and I worked in the pharmaceutical industry as a
`
`research scientist for five years.
`
`13.
`
`I hereby declare under penalty of perjury under the laws of the United
`
`States of America that the foregoing is true and correct, and that all statements
`
`made of my own knowledge are true and that all statements made on information
`
`and belief are believed to be true. I understand that willful false statements are
`
`punishable by fine or imprisonment or both. See 18 U.S.C. § 1001.
`
`Dated: November 22, 2021
`
`/s/ Jeremy Cobb
`Jeremy Cobb
`
`4
`
`Exhibit 2047
`Page 04 of 04
`
`